Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
137.00
0.00 (0.00%)
Sep 8, 2026, 12:18 PM CST

TPEX:3218 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,2744,2044,2284,0823,4942,632
Revenue Growth
0.24%-0.57%3.58%16.83%32.76%28.18%
Gross Profit
2,4872,4832,5332,4482,1401,636
Operating Income
1,3351,3801,3981,3121,081768.54
Net Income
1,1451,0431,0651,045850.53595.43
Earnings Per Share
13.4612.2612.5312.3110.027.02
EPS Growth
28.87%-2.15%1.79%22.85%42.76%23.22%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Adjustment and Elimination
-152.47-147.8-208.48-270.87--235.27
Medical Operations Department
3,2773,2593,4413,4722,7512,248
Optical Operation Department
1,1491,093995.97880.79742.82619
Total
4,2744,2044,2284,0823,4942,632

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0292,1031,9171,6411,2801,040
Total Debt
1,5081,0631,054778.26783.65767.53
Net Cash (Debt)
-478.921,040863.2862.65495.99272.47
Net Cash Growth
-20.47%0.07%73.92%82.03%-41.23%
Net Cash Per Share
-5.6312.2310.1610.165.853.21

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,7781,6661,6721,5541,268911.77
Capital Expenditures
-470.58-562.66-434.65-472.53-489.7-324.44
Free Cash Flow
1,3071,1041,2371,081778.47587.33
Free Cash Flow Growth
5.03%-10.80%14.46%38.87%32.55%10.41%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.19%59.05%59.91%59.98%61.24%62.18%
Operating Margin
31.24%32.83%33.06%32.14%30.94%29.20%
Pretax Margin
33.15%32.01%31.17%32.30%31.26%29.00%
Profit Margin
26.78%24.80%25.18%25.60%24.34%22.62%
FCF Margin
30.58%26.25%29.27%26.48%22.28%22.32%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
7.7507.7507.5007.0005.6604.492
Dividend Per Share Growth
3.33%3.33%7.14%23.67%26.00%19.05%
Dividend Yield
5.62%5.62%4.11%2.84%2.30%2.06%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
10.1811.8615.9222.4628.0536.18
Forward PE
9.8910.6615.2419.4124.6727.75
P/FCF Ratio
8.8811.2113.6921.7130.6536.68
PS Ratio
2.722.944.015.756.838.19